These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29877641)

  • 1. Association of Cannabis With Long-Term Clinical Symptoms in Anxiety and Mood Disorders: A Systematic Review of Prospective Studies.
    Mammen G; Rueda S; Roerecke M; Bonato S; Lev-Ran S; Rehm J
    J Clin Psychiatry; 2018 Jun; 79(4):. PubMed ID: 29877641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
    Tourjman SV; Buck G; Jutras-Aswad D; Khullar A; McInerney S; Saraf G; Pinto JV; Potvin S; Poulin MJ; Frey BN; Kennedy SH; Lam RW; MacQueen G; Milev R; Parikh SV; Ravindran A; McIntyre RS; Schaffer A; Taylor VH; van Ameringen M; Yatham LN; Beaulieu S
    Can J Psychiatry; 2023 May; 68(5):299-311. PubMed ID: 35711159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric symptoms in cannabis users.
    Thomas H
    Br J Psychiatry; 1993 Aug; 163():141-9. PubMed ID: 8075903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder.
    Lundahl LH; Greenwald MK
    Drug Alcohol Depend; 2016 Sep; 166():143-9. PubMed ID: 27436749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cannabis and mood].
    Sanches RF; Marques JM
    Braz J Psychiatry; 2010 Jun; 32(2):173-80. PubMed ID: 20658056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and development of dual diagnoses: A literature review.
    Hanna RC; Perez JM; Ghose S
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):442-455. PubMed ID: 27612527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychiatric complications of cannabis use].
    Coscas S; Benyamina A; Reynaud M; Karila L
    Rev Prat; 2013 Dec; 63(10):1426-8. PubMed ID: 24579344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety and mood disorders and cannabis use.
    Cheung JT; Mann RE; Ialomiteanu A; Stoduto G; Chan V; Ala-Leppilampi K; Rehm J
    Am J Drug Alcohol Abuse; 2010 Mar; 36(2):118-22. PubMed ID: 20337509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between cannabis use and anxiety disorders: Results from a population-based representative sample.
    Feingold D; Weiser M; Rehm J; Lev-Ran S
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):493-505. PubMed ID: 26775742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use and mood disorders: a systematic review.
    Sorkhou M; Dent EL; George TP
    Front Public Health; 2024; 12():1346207. PubMed ID: 38655516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of cannabis use and clinical correlates among individuals with Major Depressive Disorder and Bipolar Disorder.
    Taub S; Feingold D; Rehm J; Lev-Ran S
    Compr Psychiatry; 2018 Jan; 80():89-96. PubMed ID: 29069624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents.
    Stapinski LA; Montgomery AA; Araya R
    Drug Alcohol Depend; 2016 Sep; 166():109-15. PubMed ID: 27427415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.
    Werneck MA; Kortas GT; de Andrade AG; Castaldelli-Maia JM
    CNS Drugs; 2018 Dec; 32(12):1113-1129. PubMed ID: 30361897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis.
    Bahji A; Stephenson C; Tyo R; Hawken ER; Seitz DP
    JAMA Netw Open; 2020 Apr; 3(4):e202370. PubMed ID: 32271390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood.
    Degenhardt L; Coffey C; Romaniuk H; Swift W; Carlin JB; Hall WD; Patton GC
    Addiction; 2013 Jan; 108(1):124-33. PubMed ID: 22775447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use and mental health-related quality of life among individuals with anxiety disorders.
    Lev-Ran S; Le Foll B; McKenzie K; Rehm J
    J Anxiety Disord; 2012 Dec; 26(8):799-810. PubMed ID: 23023160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.